| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 55.300 | 58.473 | 60.295 | 60.535 | 57.051 | 59.675 | 119.228 | 146.528 | 180.558 | 181.257 |
| Total Income - EUR | 55.569 | 85.091 | 60.458 | 61.259 | 57.129 | 59.750 | 119.297 | 146.919 | 189.145 | 187.577 |
| Total Expenses - EUR | 25.197 | 43.218 | 24.932 | 29.212 | 31.541 | 22.434 | 25.078 | 27.184 | 35.342 | 18.114 |
| Gross Profit/Loss - EUR | 30.372 | 41.872 | 35.527 | 32.048 | 25.588 | 37.317 | 94.219 | 119.735 | 153.803 | 169.463 |
| Net Profit/Loss - EUR | 28.705 | 39.320 | 33.713 | 30.210 | 23.874 | 35.571 | 90.640 | 115.327 | 129.184 | 142.349 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Ray Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 29.006 | 4.845 | 36.550 | 58.542 | 42.617 | 28.545 | 14.474 | 2.157 | 906 | 563 |
| Current Assets | 64.076 | 92.703 | 79.860 | 80.560 | 116.544 | 157.359 | 131.463 | 167.654 | 190.817 | 202.064 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 19.761 | 7.157 | 4.142 | 9.375 | 17.487 | 6.144 | 10.653 | 11.560 | 45.928 | 0 |
| Cash | 44.316 | 85.546 | 75.717 | 71.185 | 99.057 | 151.215 | 120.809 | 156.095 | 144.889 | 202.064 |
| Shareholders Funds | 84.955 | 97.548 | 92.396 | 120.910 | 142.443 | 175.313 | 143.201 | 168.128 | 181.974 | 196.655 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.127 | 0 | 24.013 | 18.191 | 16.719 | 10.591 | 2.736 | 1.684 | 9.748 | 5.972 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Ray Med S.r.l.